Alphatec Holdings (ATEC) Shares Outstanding (Diluted Average) (2012 - 2026)
Alphatec Holdings' (ATEC) quarterly Shares Outstanding (Diluted Average) came in at $154.1 million in Q1 2026, up 4.99% year-on-year from $146.7 million in Q1 2025, and up 2.66% quarter-over-quarter from $150.1 million in Q4 2025.
Alphatec Holdings (ATEC) Shares Outstanding (Diluted Average) (2012 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Shares Outstanding (Diluted Average) across 11 years of filings, most recently posting $154.1 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $154.1 million, up 4.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $154.1 million (up 4.99% YoY), and the FY2025 annual result was $150.1 million, up 4.98% from the prior year.
- Shares Outstanding (Diluted Average) came in at $154.1 million for Q1 2026 at Alphatec Holdings, up from $150.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $154.1 million in Q1 2026 to a low of $100.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $141.0 million (2024), against an average of $128.9 million.
- Across the five-year window, Shares Outstanding (Diluted Average) advanced 28.45% in 2024 and rose 4.08% in 2025, its largest moves.
- Alphatec Holdings' Shares Outstanding (Diluted Average) stood at $103.4 million in 2022, then gained by 17.29% to $121.2 million in 2023, then gained by 17.9% to $142.9 million in 2024, then rose by 4.98% to $150.1 million in 2025, then increased by 2.66% to $154.1 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $154.1 million (Q1 2026), $150.1 million (Q4 2025), and $149.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Alphatec Holdings | 1.34 Bn | 1.20 Bn | 136.48 Mn | 154.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154.05 Mn |
| Dec 31, 2025 | 150.06 Mn |
| Sep 30, 2025 | 149.37 Mn |
| Jun 30, 2025 | 149.91 Mn |
| Mar 31, 2025 | 146.73 Mn |
| Dec 31, 2024 | 142.95 Mn |
| Sep 30, 2024 | 143.49 Mn |
| Jun 30, 2024 | 141.85 Mn |
| Mar 31, 2024 | 140.98 Mn |
| Dec 31, 2023 | 121.24 Mn |
| Sep 30, 2023 | 117.03 Mn |
| Jun 30, 2023 | 114.26 Mn |
| Mar 31, 2023 | 109.75 Mn |
| Dec 31, 2022 | 103.37 Mn |
| Sep 30, 2022 | 104.80 Mn |
| Jun 30, 2022 | 101.42 Mn |
| Mar 31, 2022 | 99.98 Mn |
| Dec 31, 2021 | 96.20 Mn |
| Sep 30, 2021 | 95.20 Mn |
| Jun 30, 2021 | 92.91 Mn |